Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine safety and effectiveness of transplanting kidneys
from Hepatitis C-positive donors into Hepatitis C-negative patients on the kidney transplant
waitlist, who will then be treated with the appropriate direct-acting antiviral (DAA) after
the single kidney transplantation.